Lite Strategy, Inc. (NASDAQ: LITS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT LITE STRATEGY, INC.

Lite Strategy, Inc. (NASDAQ: LITS)
Listen to this Section


$1.01
-0.0050 ( -0.50% ) 0.0K

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor.

Market Data


Open $1.01
Previous Close $1.01
Volume 0.0K
Market Cap $34.37M
Day Range $1.01 - $1.01
52 Week Range $0.69 - $3.23
Shares Outstanding 34.03M
Change % -0.50%
Net Change ▼ -0.0050
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2003
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 72 Nov 14, 2025

Latest News